Search

everythinglearnresearchcommunity

for

Search:↓

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Wheat straw is valuable for its health benefits and various industrial uses.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Portuguese WAA-QoL questionnaire validated; FPHL severity, schooling, and phototypes affect patients' quality of life.

Cytochrome P-450 enzymes in the skin help break down various substances and could be targeted to treat skin conditions.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Spin traps like PBN could protect skin from pollution and sunlight in cosmetics but need more research for safe use.

Puerariae Lobatae Radix can reduce sebaceous gland size and secretion, potentially treating related skin conditions.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Vimentin is crucial for wound healing, cell growth, and managing immune responses.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Exposure to plastics may increase the risk of irregular menstrual cycles and symptoms of hormone imbalance in teenage girls.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Isotretinoin and tazarotene help treat acne, while minoxidil and finasteride promote hair growth.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.